P.L. van Riel

3.3k total citations · 2 hit papers
34 papers, 2.5k citations indexed

About

P.L. van Riel is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, P.L. van Riel has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 7 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in P.L. van Riel's work include Rheumatoid Arthritis Research and Therapies (26 papers), Systemic Lupus Erythematosus Research (7 papers) and Biosimilars and Bioanalytical Methods (4 papers). P.L. van Riel is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (26 papers), Systemic Lupus Erythematosus Research (7 papers) and Biosimilars and Bioanalytical Methods (4 papers). P.L. van Riel collaborates with scholars based in Netherlands, Norway and United Kingdom. P.L. van Riel's co-authors include L B van de Putte, M. A. van Leeuwen, M. H. van Rijswijk, Désirée van der Heijde, M.A. van ’t Hof, E. Lubberts, Peter Tugwell, Joachim R. Kalden, FC Breedveld and Michael Schiff and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Scandinavian Journal of Rheumatology.

In The Last Decade

P.L. van Riel

33 papers receiving 2.4k citations

Hit Papers

Judging disease activity in clinical practice in rheumato... 1990 2026 2002 2014 1990 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.L. van Riel Netherlands 15 2.1k 742 350 349 243 34 2.5k
Kristina Forslind Sweden 28 2.5k 1.2× 688 0.9× 373 1.1× 420 1.2× 320 1.3× 81 3.0k
Y P M Goekoop-Ruiterman Netherlands 20 2.4k 1.1× 880 1.2× 348 1.0× 399 1.1× 485 2.0× 30 2.6k
J Rovenský Slovakia 15 1.4k 0.7× 585 0.8× 236 0.7× 534 1.5× 212 0.9× 47 2.2k
Cédric Lukas France 27 2.7k 1.3× 877 1.2× 349 1.0× 929 2.7× 233 1.0× 112 3.3k
John Sibley Canada 20 1.7k 0.8× 357 0.5× 724 2.1× 528 1.5× 229 0.9× 37 2.8k
J. Christiaan van Denderen Netherlands 16 1.8k 0.9× 631 0.9× 223 0.6× 441 1.3× 248 1.0× 26 2.2k
H. M. Markusse Netherlands 18 1.5k 0.7× 552 0.7× 268 0.8× 202 0.6× 246 1.0× 43 2.2k
Anke M. van Gestel Netherlands 17 3.3k 1.5× 1.3k 1.8× 582 1.7× 605 1.7× 579 2.4× 24 3.7k
D. van Zeben Netherlands 24 3.3k 1.6× 1.4k 1.8× 494 1.4× 571 1.6× 681 2.8× 41 3.9k
Siegfried Wassenberg Germany 21 1.8k 0.9× 726 1.0× 173 0.5× 716 2.1× 186 0.8× 61 2.2k

Countries citing papers authored by P.L. van Riel

Since Specialization
Citations

This map shows the geographic impact of P.L. van Riel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.L. van Riel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.L. van Riel more than expected).

Fields of papers citing papers by P.L. van Riel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.L. van Riel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.L. van Riel. The network helps show where P.L. van Riel may publish in the future.

Co-authorship network of co-authors of P.L. van Riel

This figure shows the co-authorship network connecting the top 25 collaborators of P.L. van Riel. A scholar is included among the top collaborators of P.L. van Riel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.L. van Riel. P.L. van Riel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rollefstad, Silvia, Eirik Ikdahl, Cynthia S. Crowson, et al.. (2016). THU0634 Sex Differences in Cardiovascular Risk Factors and Event Rates in Patients with Rheumatoid Arthritis - Data from 13 Rheumatology Centers. Annals of the Rheumatic Diseases. 75. 423–423. 1 indexed citations
2.
Arts, Elke, Călin D. Popa, Alfons A den Broeder, et al.. (2014). Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases. 74(4). 668–674. 206 indexed citations
3.
Plantinga, Theo S., Jaap Fransen, Rachel Knevel, et al.. (2013). Role of NOD1 polymorphism in susceptibility and clinical progression of rheumatoid arthritis. Lara D. Veeken. 52(5). 806–814. 14 indexed citations
4.
Vermeer, M., A. E. van der Bijl, Marcel D. Posthumus, et al.. (2012). The new ACR / EULAR Definition of Remission in Rheumatoid Arthritis: Is the Patient Global Assessment Criterion too strict?. Annals of the Rheumatic Diseases. 70. 178. 4 indexed citations
5.
Vermeer, M., H. H. Kuper, Monique Hoekstra, et al.. (2010). Radiological progression in very early rheumatoid arthritis, results of the DREAM remission induction cohort. Data Archiving and Networked Services (DANS). 66. 1 indexed citations
6.
Taal, Erik, et al.. (2010). Responsiveness of the EQ-5D and SF-6D to improvement in patients with Rheumatoid Arthritis receiving a first TNF-blocker: results of the DREAM registry. University of Twente Research Information. 1 indexed citations
7.
Kievit, Wietske, M.C.W. Creemers, Jaap Fransen, et al.. (2006). A higher rate of serious infections in patients treated with TNF blocking agents. University of Twente Research Information. 2 indexed citations
8.
Kievit, Wietske, Jaap Fransen, H. H. Kuper, et al.. (2006). The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice. University of Twente Research Information. 6 indexed citations
9.
Smolen, Josef S, FC Breedveld, Michael Schiff, et al.. (2003). A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Lara D. Veeken. 42(2). 244–257. 795 indexed citations breakdown →
10.
Radstake, Timothy R. D. J., Pilar Barrera, Marcel J. I. J. Albers, et al.. (2001). Genetic anticipation in rheumatoid arthritis in Europe. European Consortium on Rheumatoid Arthritis Families.. PubMed. 28(5). 962–7. 20 indexed citations
11.
Laan, Roland, Tim Jansen, & P.L. van Riel. (1999). Glucocorticosteroids in the management of rheumatoid arthritis. Lara D. Veeken. 38(1). 6–12. 55 indexed citations
12.
Riel, P.L. van, et al.. (1999). Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease.. PubMed. 26(2). 268–76. 21 indexed citations
13.
Jansen, Tim, M. Janssen, & P.L. van Riel. (1998). Grand rounds in rheumatology: acute rheumatic fever or post- streptococcal reactive arthritis: a clinical problem revisited [clinical conference]. Lara D. Veeken. 37(3). 335–340. 23 indexed citations
14.
Gestel, Anke M. van, Roland Laan, C.J. Haagsma, L B van de Putte, & P.L. van Riel. (1995). ORAL STEROIDS AS BRIDGE THERAPY IN RHEUMATOID ARTHRITIS PATIENTS STARTING WITH PARENTERAL GOLD. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. Lara D. Veeken. 34(4). 347–351. 66 indexed citations
15.
Boers, Maarten, P.L. van Riel, David T. Felson, & Peter Tugwell. (1995). Assessing the activity of rheumatoid arthritis. Baillière s Clinical Rheumatology. 9(2). 305–317. 22 indexed citations
16.
Laan, Roland, W C Buijs, André L. M. Verbeek, et al.. (1993). Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity.. Annals of the Rheumatic Diseases. 52(1). 21–26. 130 indexed citations
17.
Laan, Roland, P.L. van Riel, & L B van de Putte. (1992). Bone mass in osteoarthritis.. Annals of the Rheumatic Diseases. 51(6). 826–832. 62 indexed citations
18.
Nuver-Zwart, I. H., et al.. (1991). Hemolysis During Low-dose Sutfasalazine Treatment in Rheumatoid Arthritis Patients. Scandinavian Journal of Rheumatology. 20(1). 52–57. 1 indexed citations
19.
Perret, C., et al.. (1990). Generalized Urticarial Eruption during Azathioprine Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature. Scandinavian Journal of Rheumatology. 19(2). 167–169. 1 indexed citations
20.
Riel, P.L. van. (1984). Serum IgA and gold-induced toxic effects in patients with rheumatoid arthritis. Archives of Internal Medicine. 144(7). 1401–1403. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026